Product Reports Resources Pricing Login Book a demo
Kirk Nielsen
Person deep dive

Kirk Nielsen

#67 2026 Strebulaev–Jackson Venture Ranking, emerging firms

Kirk Nielsen co-founded Vensana Capital in 2019 to invest in medical technology, after leading the medtech practice at Versant Ventures. He has led or co-led investments in companies that exited, including Inari Medical, which went public, and Vensana closed a $425M third fund in 2025.

Founded
Vensana Capital
Education
Harvard Business School

Track record

Investments Kirk Nielsen is best known for, with what became of them.

Vensana Capital

FirmVensana Capital
Founded2019
Based inMinneapolis
Funds$425M Fund III closed in January 2025
FocusMedical technology, from development to commercial stage

Career

  1. 2006Joined Versant Ventures from Medtronic's Cardiac Rhythm Management division, after working at Fluidigm and Bain & Company and playing professional hockey.
  2. 2019Co-founded Vensana Capital.
  3. 2025Vensana closed its third fund at $425M.
  4. 2026Portfolio company SpyGlass Pharma priced its IPO.

Sources: Vensana Capital: team · Vensana Capital: $425M Fund III (2025) · Vensana Capital: SpyGlass Pharma IPO pricing · Dealroom person profile. Rank: 2026 Strebulaev–Jackson Venture Ranking.

Companies founded

Vensana Capital
Founder · Managing Partner · Partner · 2018 – present

Currently

Active roles, board seats and partnerships.

Work history

Past roles by Dealroom records.

National Venture Capital Association
Board Member · 2020 – 2024
Medtronic
Business Development Manager · 2003 – 2006
$132B valuation (2026)
→
Bain & Company
Consultant · Strategy Consultant · 1999 – 2002
Standard Biotools
Business Development Manager
$257.2M valuation (2026)
→

Education

Harvard Business School
MBA · 2002 – 2004
← All people